Clinical Therapeutics

Clinical Therapeutics

临床治疗学

  • 4区 中科院分区
  • Q2 JCR分区

期刊简介

《Clinical Therapeutics》是由Elsevier Inc.出版社于1977年创办的英文国际期刊(ISSN: 0149-2918,E-ISSN: 1879-114X),该期刊长期致力于药学领域的创新研究,主要研究方向为医学-药学。作为SCIE收录期刊(JCR分区 Q2,中科院 4区),本刊采用OA未开放获取模式(OA占比0.2200...%),以发表药学领域等方向的原创性研究为核心(研究类文章占比61.48%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在135篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Clinical Therapeutics审稿周期约为 一般,3-8周 约9周。该刊近年未被列入国际预警名单,年发文量约135篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 135 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
PHARMACOLOGY & PHARMACY 药学
3区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 124 / 354

65.1%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 154 / 354

56.64%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:6 SJR:0.875 SNIP:1
学科类别 分区 排名 百分位
大类:Medicine 小类:Pharmacology (medical) Q2 77 / 272

71%

大类:Medicine 小类:Pharmacology Q2 122 / 313

61%

期刊发文

  • Derivation and Evaluation of the Ischemic Risk Model in High-Risk Chinese Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome

    Author: Yanguo Xin, Yinan Zhao, Xin Chen, Junli Li, Zhiyue Liu, Xiaofan Cao, Yingxian Sun, Wenyu Hu

    Journal: CLINICAL THERAPEUTICS, 2019, Vol., , DOI:10.1016/j.clinthera.2019.03.001

  • Comparative Effectiveness of Pemetrexed-platinum Doublet Chemotherapy With or Without Bevacizumab as First-line Therapy for Treatment-naive Patients With Advanced Nonsquamous Non–small-cell Lung Cancer in China

    Author: Xiaoyou Li, Muhammad Abbas, Yun Li, Yue Teng, Ying Fang, Shaorong Yu, Yi Wen, Li Wang, Meiqi Shi

    Journal: CLINICAL THERAPEUTICS, 2019, Vol.41, 518-529, DOI:10.1016/j.clinthera.2019.02.004

  • Population Pharmacokinetics Study of Nemonoxacin Among Chinese Patients With Moderate Hepatic Impairment

    Author: Yue Kang, Yi Li, Fengyan Xu, Jing Zhang, Kun Wang, Yuancheng Chen, Jufang Wu, Beining Guo, Jicheng Yu, Yingyuan Zhang

    Journal: CLINICAL THERAPEUTICS, 2019, Vol.41, 505-517.e0, DOI:10.1016/j.clinthera.2019.01.015

  • Impact of Optimal Medical Therapy at Discharge on One-year Direct Medical Costs in Patients with Acute Coronary Syndromes: A Retrospective, Observational Database Analysis in China

    Author: Xiaoning He, Yumei Wang, Hongliang Cong, Chengzhi Lu, Jing Wu

    Journal: CLINICAL THERAPEUTICS, 2019, Vol.41, 456-465.e2, DOI:10.1016/j.clinthera.2019.01.005

  • Cyclophosphamide + Thalidomide + Dexamethasone Versus Melphalan + Dexamethasone for the Treatment of Amyloid Light-chain Amyloidosis With Kidney Involvement: A Retrospective Study in Chinese Patients

    Author: Baojian Liu, Yan Wang, Ming Bai, Di Wang, Jin Zhao, Ming Zhang, Shiren Sun

    Journal: CLINICAL THERAPEUTICS, 2019, Vol., , DOI:10.1016/j.clinthera.2018.12.003

  • Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Insulin-naive Chinese Patients With Type 2 Diabetes

    Author: Huafeng Cheng, Xu Wan, Jing Ma, Bin Wu

    Journal: CLINICAL THERAPEUTICS, 2019, Vol.41, 445-455.e4, DOI:10.1016/j.clinthera.2019.01.003

  • Effects of Sodium-glucose Cotransporter 2 Inhibitor Monotherapy on Weight Changes in Patients With Type 2 Diabetes Mellitus: a Bayesian Network Meta-analysis

    Author: Hongmei Wang, Jiadan Yang, Xi Chen, Feng Qiu, Juan Li

    Journal: CLINICAL THERAPEUTICS, 2019, Vol.41, 322-334.e11, DOI:10.1016/j.clinthera.2019.01.001

  • Pharmacokinetics and Safety of Enzalutamide in Healthy Chinese Male Volunteers

    Author: Yan-Mei Liu, Peggy Wu, Risa Fukushi, Shunsuke Yamada, Qian Chen

    Journal: CLINICAL THERAPEUTICS, 2019, Vol., , DOI:10.1016/j.clinthera.2018.12.002